Literature DB >> 15580486

Levetiracetam in the treatment of vascular chorea: a case report.

Marco D'Amelio, Graziella Callari, Matilde Gammino, Valentina Saia, Innocenzo Lupo, Giuseppe Salemi, Paolo Ragonese, Giovanni Savettieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15580486     DOI： 10.1007/s00228-004-0842-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Cause and course in a series of patients with sporadic chorea.

Authors:  Immacolata Piccolo; Carlo Alberto Defanti; Paola Soliveri; Maria Antonietta Volontè; Giuliana Cislaghi; Floriano Girotti
Journal:  J Neurol       Date:  2003-04       Impact factor: 4.849

2.  Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.

Authors:  Michael P Hill; Erwan Bezard; Steven G McGuire; Alan R Crossman; Jonathan M Brotchie; Ann Michel; Renee Grimée; Henrik Klitgaard
Journal:  Mov Disord       Date:  2003-11       Impact factor: 10.338

3.  Levetiracetam as a treatment for tardive dyskinesia: a case report.

Authors:  Cameron L McGavin; Vineeth John; William S Musser
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

4.  [Vascular hemichorea: clinical-radiological correlation].

Authors:  R Galiano; J Juni; A Castillo; J Parra; C Peiró; J Sancho
Journal:  Rev Neurol       Date:  2000 Mar 1-15       Impact factor: 0.870

5.  Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs.

Authors:  D G Margineanu; H Klitgaard
Journal:  Pharmacol Res       Date:  2000-10       Impact factor: 7.658

Review 6.  Some common issues in the use of antiepileptic drugs.

Authors:  Jorge J Asconapé
Journal:  Semin Neurol       Date:  2002-03       Impact factor: 3.420

7.  Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis.

Authors:  Anjan Chatterjee; Elan D Louis; Steven Frucht
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

8.  Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome.

Authors:  Stephan J Rüegg; Andreas J Steck; Peter Fuhr
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

9.  Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy.

Authors:  Henrik Klitgaard; Alain Matagne; Renee Grimee; Jocelyne Vanneste-Goemaere; Doru-Georg Margineanu
Journal:  Seizure       Date:  2003-03       Impact factor: 3.184

10.  Treatment of vascular hemiballism and hemichorea.

Authors:  W G Johnson; S Fahn
Journal:  Neurology       Date:  1977-07       Impact factor: 9.910
  10 in total
  6 in total

1.  Treatment of chorea with levetiracetam.

Authors:  Theresa A Zesiewicz; Amit Pathak; Kelly L Sullivan; Mikhail Shamayev; Robert A Hauser
Journal:  Eur J Clin Pharmacol       Date:  2005-12-01       Impact factor: 2.953

Review 2.  Levetiracetam Mechanisms of Action: From Molecules to Systems.

Authors:  Itzel Jatziri Contreras-García; Noemí Cárdenas-Rodríguez; Antonio Romo-Mancillas; Cindy Bandala; Sergio R Zamudio; Saúl Gómez-Manzo; Beatriz Hernández-Ochoa; Julieta Griselda Mendoza-Torreblanca; Luz Adriana Pichardo-Macías
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-13

3.  Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.

Authors:  Tibor Kovács; Marianna Farsang; Edina Vitaszil; Péter Barsi; Tamás Györke; Imre Szirmai; Anita Kamondi
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

4.  Use of antiepileptic drugs for hyperkinetic movement disorders.

Authors:  A Siniscalchi; L Gallelli; G De Sarro
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

Review 5.  Post-stroke dyskinesias.

Authors:  Mohammad Obadah Nakawah; Eugene C Lai
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-07       Impact factor: 2.570

6.  Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management.

Authors:  Antonio Siniscalchi; Luca Gallelli; Angelo Labate; Giovanni Malferrari; Caterina Palleria; Giovambattista De Sarro
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.